The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Arber, Daniel A., Orazi, Attilio, Hasserjian, Robert, Thiele, Jürgen, Borowitz, Michael J., Le Beau, Michelle M., Bloomfield, Clara D., Cazzola, Mario +1 more·2016·Blood

DOI 10.1182/blood-2016-03-643544

Cited by (1,019)

Items 601–700 of 1,019

Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2
Constance Regina Baer, Verena Mühlbacher, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach · 2018 · Haematologica
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms
Graeme Greenfield, Suzanne McPherson, Ken Mills, Mary Frances McMullin · 2018 · Journal of Translational Medicine
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series
Isaac Goncalves, Kate Burbury, Michael Michael, Amir Iravani, Aravind S. Ravi Kumar, Tim J. Akhurst, Ing Soo Tiong, Piers A. Blombery, Michael S. Hofman, David Westerman et al. · 2019 · European Journal of Nuclear Medicine and Molecular Imaging
Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?
Michael Heuser · 2016 · Hematology
Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients
Etienne De Clara, Morgane Gourvest, Hanjing Ma, François Vergez, Marie Tosolini, Sébastien Dejean, Cécile Demur, Éric Delabesse, Christian Récher, Christian Touriol et al. · 2017 · Haematologica
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes
Yasunobu Nagata, Hideki Makishima, Cassandra M Kerr, Bartlomiej P. Przychodzen, Mai Mostafa Aly, Abhinav Goyal, Hassan K. Awada, Mohammad Asad, Teodora Kuzmanovic, Hiromichi Suzuki et al. · 2019 · Nature Communications
EZH2 in Myeloid Malignancies
Jenny Rinke, Andrew Chase, Nicholas C.P. Cross, Andreas Hochhaus, Thomas Ernst · 2020 · Cells
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study
Francisco Cervantes, David M. Ross, Atanas Radinoff, Francesca Palandri, Alexandr Myasnikov, Alessandro Maria Vannucchi, Pierre Zachée, Heinz Gisslinger, Norio Komatsu, Lynda M. Foltz et al. · 2021 · Leukemia
Real‐Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT‐HU cohort study
Mariane de Montalembert, Ersi Voskaridou, Lena Oevermann, Giovanna Cannas, Anoosha Habibi, Gylna Loko, Laure Joseph, Raffaella Colombatti, Pablo Bartolucci, Valentine A.M. Brousse et al. · 2021 · American Journal of Hematology
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study
David Martínez‐Cuadrón, Juan Eduardo Megías‐Vericat, Josefina Serrano, Pilar Martínez‐Sánchez, Eduardo Rodriguez Arboli, Cristina Gil, Eliana Vale Aguiar, Juan Bergua, José Luis López Lorenzo, Teresa Bernal et al. · 2021 · Blood Advances
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
Jan‐Niklas Eckardt, Friedrich Stölzel, Desireé Kunadt, Christoph Röllig, Sebastian Stasik, Lisa Wagenführ, Korinna Jöhrens, Friederike Kuithan, Alwin Krämer, Sebastian Scholl et al. · 2022 · Journal of Hematology & Oncology
Explainable AI identifies diagnostic cells of genetic AML subtypes
Matthias Hehr, Ario Sadafi, Christian Matek, Peter Lienemann, Christian Pohlkamp, Torsten Haferlach, Karsten Spiekermann, Carsten Marr · 2023 · PLOS Digital Health
The international consensus classification of eosinophilic disorders and systemic mastocytosis
Sa A. Wang, Attilio Orazi, Jason R. Gotlib, Andreas Reiter, Alexandar Tzankov, Robert Paul Hasserjian, Daniel A. Arber, Ayalew Tefferi · 2023 · American Journal of Hematology
Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures
Jermaine L. Jenkins, Clara L. Kielkopf · 2017 · Trends in Genetics
Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells
Xin Zhao, Shouguo Gao, Zhijie Wu, Sachiko Kajigaya, Xingmin Feng, Qingguo Liu, Danielle Michelle Townsley, James Cooper, Jinguo Chen, Keyvan Keyvanfar et al. · 2017 · Blood
Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes
Bing Li, Jinqin Liu, Yujiao Jia, Jingya Wang, Zefeng Xu, Tiejun Qin, Zhongxun Shi, Zhen Song, Shuailing Peng, Huijun Huang et al. · 2017 · Genes Chromosomes and Cancer
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML
Peter Valent, Wolfgang Kern, Gregor Hoermann, Jelena D. Milosevic Feenstra, Karl Sotlar, Michael Pfeilstöcker, Ulrich Germing, Wolfgang R. Sperr, Andreas Reiter, Dominik Georg Friedrich Wolf et al. · 2019 · International Journal of Molecular Sciences
CD8+ T cells exhaustion induced by myeloid‐derived suppressor cells in myelodysplastic syndromes patients might be through TIM3/Gal‐9 pathway
Jinglian Tao, Dong Han, Shan Gao, Wei Zhang, Hong Yu, Pei Liu, Rong Fu, Lijuan Li, Zonghong Shao · 2019 · Journal of Cellular and Molecular Medicine
Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
Guillermo Montalban Bravo, Koichi Takahashi, Keyur Pravinchandra Patel, Feng Wang, Song Xingzhi, Graciela M. Nogueras, Xuelin Huang, Ana Alfonso Piérola, Elias Joseph Jabbour, Simona Colla et al. · 2018 · Oncotarget
Clonal hematopoiesis as a model for premalignant changes during aging
David P. Steensma, Benjamin L. Ebert · 2019 · Experimental Hematology
Systematic Review and Meta-analysis of CD19-Specific CAR-T Cell Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia in the Pediatric and Young Adult Population: Safety and Efficacy Outcomes
Sobia Aamir, Muhammad Yasir Anwar, Farhan Khalid, Sana Irfan Khan, Muhammad Ashar Ali, Zoia Ehsan Khattak · 2020 · Clinical Lymphoma Myeloma & Leukemia
Erythrocytosis in the general population: clinical characteristics and association with clonal hematopoiesis
Hanneke J. C. M. Wouters, René Mulder, Isabelle A. van Zeventer, Jan Jacob Schuringa, Melanie M. van der Klauw, Pim van der Harst, Arjan Diepstra, André B. Mulder, Gerwin A. Huls · 2020 · Blood Advances
Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS
Oscar E. Brück, Susanna E. Lallukka-Brück, Helena R. Hohtari, Aleksandr Ianevski, Freja T. Ebeling, Panu E. Kovanen, Soili I. Kytölä, Tero A. Aittokallio, Pedro Marques Ramos, Kimmo Porkka et al. · 2021 · Blood Cancer Discovery
Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party
Donal P. McLornan, Juan Carlos Hernández‐Boluda, Tomasz Czerw, Nicholas C.P. Cross, H. Joachim Deeg, Markus Ditschkowski, Mufaddal T. Moonim, Nicola Polverelli, Marie Robin, Mahmoud Deeb Aljurf et al. · 2021 · Leukemia
Changes in the incidence and overall survival of patients with myeloproliferative neoplasms between 2002 and 2016 in the United States
Srđan Verstovšek, Jingbo Yu, Robyn Marie Scherber, Sumit Verma, Christopher Dieyi, Chien-Cheng Chen, Shreekant V. Parasuraman · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms
Nikhil Sahajpal, Ashis Kumar Mondal, Tatiana Tvrdik, Jen Hauenstein, Huidong Shi, Kristin K. Deeb, Debra Saxe, Alex R. Hastie, Alka Chaubey, Natasha M. Savage et al. · 2022 · Journal of Molecular Diagnostics
Artificial Intelligence-Assisted Diagnostic Cytology and Genomic Testing for Hematologic Disorders
Lealem Gedefaw, Chia-Fei Liu, Rosalina K. L. Ip, Hing-Fung Tse, Martin Ho Yin Yeung, Shea Ping Yip, Chien‐Ling Huang · 2023 · Cells
BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesis
Magnús Halldór Gíslason, Gül Sude Demircan, Marek Prachař, Benjamin Furtwängler, Juerg Schwaller, Erwin M. Schoof, Bo Torben Porse, Nicolas Rapin, Frederik Otzen Bagger · 2023 · Nucleic Acids Research
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium
Amer Methqal Zeidan, Najla E. Al Ali, John Barnard, Eric Padron, Jeffrey E. Lancet, Mikkael Aaron Sekeres, David P. Steensma, Amy Elizabeth Dezern, Gail J. Roboz, Elias Joseph Jabbour et al. · 2017 · Leukemia
Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm
Kyogo Suzuki, Yuka Suzuki, Asahito Hama, Hideki Muramatsu, Masahiro Nakatochi, Mariko Gunji, Daisuke Ichikawa, Motoharu Hamada, Rieko Taniguchi, Shinsuke Kataoka et al. · 2017 · Leukemia
Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group
Sanne Noort, Martin Zimmermann, Dirk Reinhardt, Wendy Cuccuini, Martina Pigazzi, Jenny L. Smith, Rhonda E. Ries, Todd A. Alonzo, Betsy A Hirsch, Daisuke Tomizawa et al. · 2018 · Blood
Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes
Yasunobu Nagata, Satoshi Narumi, Yihong Guan, Bartlomiej P. Przychodzen, Cassandra M. Hirsch, Hideki Makishima, Hirohito Shima, Mai Mostafa Aly, Víctor Manuel López Pastor, Teodora Kuzmanovic et al. · 2018 · Blood
Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all- trans retinoic acid in acute myeloid leukemia across subtypes
Kimberly N. Smitheman, Tesa Severson, Satyajit Rajapurkar, Michael T. McCabe, Natalie O. Karpinich, James J. Foley, Melissa Baker Pappalardi, Ashley M. Hughes, Wendy S. Halsey, Elizabeth Thomas et al. · 2018 · Haematologica
Association of Leukemia Cutis With Survival in Acute Myeloid Leukemia
Cynthia X. Wang, Iskra Pusic, Milan J. Anadkat · 2019 · JAMA Dermatology
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives
Fabio Forghieri, Patrizia Comoli, Roberto Marasca, Leonardo Potenza, Mario Luppi · 2018 · International Journal of Molecular Sciences
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, Matthias Stelljes, Verena I. Gaidzik, Michael Lauseker, Oliver Kriege, Mareike Verbeek, Julia Marie Unglaub, Felicitas R. Thol et al. · 2021 · Blood Cancer Journal
Single-cell genomics in AML: extending the frontiers of AML research
Asiri Ediriwickrema, Andrew J. Gentles, Ravindra Majeti · 2022 · Blood
miR-139-5p controls translation in myeloid leukemia through EIF4G2
Stephan Emmrich, F Engeland, Mona El-Khatib, Kerstin Henke, Askar Obulkasim, J Schöning, Jenny E. Katsman-Kuipers, Christian Michel Zwaan, Andreas Pich, Jan Starý et al. · 2015 · Oncogene
GSK3 Deficiencies in Hematopoietic Stem Cells Initiate Pre-neoplastic State that Is Predictive of Clinical Outcomes of Human Acute Leukemia
Borhane Guezguez, Mohammed Almakadi, Yannick D. Benoit, Zoya Shapovalova, Susann Rahmig, Aline Fiebig‐Comyn, Fanny Lys Casado, Borko Tanasijevic, Silvia Bresolin, Riccardo Masetti et al. · 2016 · Cancer Cell
Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia
Mohammad Faizan Zahid, Daniela Barraco, Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Naseema Gangat, Curtis A. Hanson, Ayalew Tefferi, Mrinal M. Patnaik · 2016 · Leukemia & lymphoma/Leukemia and lymphoma
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia
A-K Eisfeld, Jessica Kohlschmidt, Sebastian Schwind, Deedra Nicolet, James Stewart Blachly, Shelley J. Orwick, Chandni Shah, Maryam A. Bainazar, Karl W. Kroll, Christopher James Walker et al. · 2016 · Leukemia
Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis
Sebastian Fernandez‐Pol, Lisa Ma, Robert Shigeo Ohgami, Daniel A. Arber · 2016 · Modern Pathology
Pure erythroid leukemia
Wei Wang, Sa A. Wang, Leonard Jeffrey Medeiros, Joseph David Khoury · 2016 · American Journal of Hematology
Familial CEBPA-mutated acute myeloid leukemia
Kiran Tawana, Ana Rio‐Machín, Claude Preudhomme, Jude Fitzgibbon · 2017 · Seminars in Hematology
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome
Deepak Singhal, Monika Kutyna, Rakchha Chhetri, Li Yan A. Wee, Sophia Hague, Lakshmi Nath, Shriram Vaidia Nath, R. K. Sinha, Nicholas W. R. Wickham, Ian D. Lewis et al. · 2017 · Haematologica
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant
Meagan A. Jacoby, Eric J. Duncavage, Gue Su Chang, Christopher A. Miller, Jin Shao, Kevin Elliott, Joshua Robinson, Robert S. Fulton, Catrina C. Fronick, Michelle D. O’Laughlin et al. · 2018 · JCI Insight
Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia
Mehrdad Hefazi, Mark Robert Litzow · 2018 · Current Hematologic Malignancy Reports
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T‐ALL like mutations
Xiaoli Mi, Gabriel Kenneth Griffin, Winston Lee, Sanjay S. Patel, Robert Shigeo Ohgami, Chi Young Ok, Sa Wang, Julia Turbiner Geyer, Wenbin Xiao, Mikhail Roshal et al. · 2018 · American Journal of Hematology
JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation
Julia Czech, Sabrina Cordua, Barbora Weinbergerová, Julian Baumeister, Assja Crepcia, Lijuan Han, Tiago Maié, Ivan G. Costa, Bernd Denecke, Angela Maurer et al. · 2018 · Leukemia
Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states
Lukasz P. Gondek, Amy Elizabeth Dezern · 2019 · The Lancet Haematology
NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells
Qin Zou, Shi Tan, Zailin Yang, Qian Zhan, Hongjun Jin, Jingrong Xian, Shuaishuai Zhang, Liyuan Yang, Lu Wang, Ling Zhang · 2017 · Theranostics
Cutaneous Mastocytosis in Adults and Children
Almudena Matito, José Manuel Azaña Defez, Antonio Torrelo, Iván Álvarez‐Twöse · 2018 · Immunology and Allergy Clinics of North America
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
Hélène Guermouche, Noémie Ravalet, Nathalie Gallay, Caroline Deswarte, Amélie Foucault, Jenny Beaud, Emmanuelle Rault, Emeline Saindoy, Sébastien Lachot, Jean‐Alain Martignoles et al. · 2020 · Blood Advances
International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia
Maximilian Schönung, Julia Meyer, Peter Noellke, Adam B. Olshen, Mark Hartmann, Norihiro Murakami, Manabu Wakamatsu, Yusuke Okuno, Christoph Plass, Mignon L. Loh et al. · 2020 · Clinical Cancer Research
Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center
Xue Chen, Fang Wang, Yang Zhang, Xiaoli Ma, Panxiang Cao, Lili Yuan, Lan Wang, Jiaqi Chen, Xiaosu Zhou, Qisheng Wu et al. · 2021 · Blood Cancer Journal
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies
Anna Stengel, Constance Regina Baer, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach · 2021 · Blood Advances
Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
Marta Malczewska, Kamil Kośmider, Kinga Bednarz, Katarzyna Ostapińska, Monika Lejman, Joanna Zawitkowska · 2022 · Cancers
The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions
Sunil Girish Iyer, Laila Elias, Michele Stanchina, Justin M. Watts · 2023 · Frontiers in Oncology
NPM1 ‐mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions
Brunangelo Falini · 2023 · American Journal of Hematology
How I treat atypical chronic myeloid leukemia
Jason R. Gotlib · 2016 · Blood
Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression
Michihide Tokuhira, Shuntaro Saito, Ayumi Okuyama, Katsuya Suzuki, Morihiro Higashi, Shuji Momose, Takayuki Shimizu, Takehiko Mori, Tomoe Anan-Nemoto, Koichi Amano et al. · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group
Alice Marceau‐Renaut, Nicolas Duployez, Benoît Ducourneau, Myriam Labopin, Arnaud Petit, Alexandra Rousseau, Sandrine Geffroy, Maxime Bucci, Wendy Cuccuini, Odile Fenneteau et al. · 2018 · HemaSphere
Time to repeal and replace response criteria for acute myeloid leukemia?
Clara Derber Bloomfield, Elihu H. Estey, Lisa Pleyer, Andre C. Schuh, Eytan M. Stein, Martin S. Tallman, Andrew H. Wei · 2018 · Blood Reviews
A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs
Dorota Link-Lenczowska, Niels Pallisgaard, Sabrina Cordua, Magdalena Zawada, Sylwia Czekalska, Dorota Krochmalczyk, Zuzanna Kanduła, Tomasz Sacha · 2018 · Annals of Hematology
Clinical effectiveness and safety of erythropoietin‐stimulating agents for the treatment of low‐ and intermediate‐1−risk myelodysplastic syndrome: a systematic literature review
Sophie Park, Peter L. Greenberg, Aylin Yucel, Caroline Farmer, Frank O'Neill, Cisio De Oliveira Brandao, Pierre Fenaux · 2018 · British Journal of Haematology
A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms
Eva N. Hamulyák, Joost G. Daams, Frank W.G. Leebeek, Bart J. Biemond, Peter A.W. te Boekhorst, Saskia Middeldorp, Mandy N. Lauw · 2021 · Blood Advances
Myeloid sarcoma
Omar Ahmad Shahin, Farhad Ravandi · 2020 · Current Opinion in Hematology
A Hematologist-Level Deep Learning Algorithm (BMSNet) for Assessing the Morphologies of Single Nuclear Balls in Bone Marrow Smears: Algorithm Development
Yi‐Ying Wu, Tzu‐Chuan Huang, Ren‐Hua Ye, Wen‐Hui Fang, Shiue‐Wei Lai, Ping‐Ying Chang, Wei-Nung Liu, Tai-Yu Kuo, Cho‐Hao Lee, Wen‐Chiuan Tsai et al. · 2020 · JMIR Medical Informatics
Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants
Elena Masselli, Giulia Pozzi, Giuliana Gobbi, Stefania Merighi, Stefania Gessi, Marco Vitale, Cecilia Carubbi · 2020 · Cells
Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD)
Quentin Neven, Cécile Boulanger, Annelyse Bruwier, Maëlle de Ville de Goyet, Isabelle Meyts, Leen Moens, An Van Damme, Bénédicte Brichard · 2020 · Journal of Clinical Immunology
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Dahlager Jørgensen, Uffe Klausen, Stine Emilie Weis-Banke, Daniel El Fassi, Claudia Schöllkopf, Mette Borg Clausen, Lise Mette Rahbek Gjerdrum, Marie Fredslund Breinholt et al. · 2021 · Frontiers in Oncology
Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)
Lina Shao, Yassmine M. N. Akkari, Linda D. Cooley, David T. Miller, Bryce A. Seifert, Daynna J. Wolff, Fady M. Mikhail · 2021 · Genetics in Medicine
Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach
Daniel A. Arber, Robert Paul Hasserjian, Attilio Orazi, Vikram Mathews, Andrew Warwick Roberts, Charles Alan Schiffer, Anne Stidsholt Roug, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi · 2022 · American Journal of Hematology
The dual role of autophagy in acute myeloid leukemia
Wonhyoung Seo, Prashanta Silwal, Ik‐Chan Song, Eun‐Kyeong Jo · 2022 · Journal of Hematology & Oncology
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Lynn Sweet, Eunice S. Wang, Jayastu Senapati, Nathaniel R. Wilson, Marina Y Konopleva, Arthur Edward Frankel, Vikas K Gupta, Ruben A. Mesa et al. · 2022 · Blood
Risk prediction for clonal cytopenia: multicenter real-world evidence
Zhuoer Xie, Rami S. Komrokji, Najla Al‐Ali, Alexandra Regelson, Susan Michelle Geyer, Anand Ashwin Patel, Caner Saygin, Amer Methqal Zeidan, Jan Philipp Bewersdorf, Lourdes Mendez et al. · 2024 · Blood
Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy
Ofir Wolach, Richard Maury Stone · 2017 · Current Opinion in Hematology
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera
Federico Lussana, Alessandra Carobbio, Silvia Salmoiraghi, Paola Guglielmelli, Alessandro Maria Vannucchi, Barbara Bottazzi, Roberto Leone, Alberto Mantovani, Tiziano Barbui, Alessandro Rambaldi · 2017 · Journal of Hematology & Oncology
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria
Elisa Rumi, the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators, Emanuela Boveri, Marta Bellini, Daniela Pietra, Virginia Valeria Ferretti, Emanuela Sant’Antonio, Chiara Cavalloni, Ilaria Carola Casetti, Elisa Roncoroni et al. · 2017 · Oncotarget
How we diagnose and treat systemic mastocytosis in adults
Robyn Marie Scherber, Uma Borate · 2017 · British Journal of Haematology
Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
Alexandra G. Smith, Debra A. Howell, Simon Crouch, Daniel Painter, John Blasé, Han‐I Wang, Ann Hewison, Timothy Bagguley, Simon Appleton, Sally E. Kinsey et al. · 2018 · International Journal of Epidemiology
PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation
Wenbin Xiao, Maheetha C. Bharadwaj, Max Fine Levine, Noushin Rahnamay Farnoud, Friederike Pastore, Bartlomiej M. Getta, Anne Hultquist, Christopher A. Famulare, Juan Santiago Medina-Martinez, Minal A. Patel et al. · 2018 · Blood Advances
Thrombosis among 1537 patients with JAK2 V617F ‐mutated myeloproliferative neoplasms: Risk factors and development of a predictive model
Yuhui Zhang, Yuan Zhou, Yingshao Wang, Guangshuai Teng, Dapeng Li, Yan Wang, Chenxiao Du, Ya‐Fang Chen, Huiqin Zhang, Yanqi Li et al. · 2020 · Cancer Medicine
Current management strategies for polycythemia vera and essential thrombocythemia
Paola Guglielmelli, Alessandro Maria Vannucchi · 2020 · Blood Reviews
New Perspectives on Polycythemia Vera: From Diagnosis to Therapy
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, Luca Baldini · 2020 · International Journal of Molecular Sciences
Clonal Hematopoiesis and Atherosclerosis
Siddhartha Jaiswal, Pradeep Natarajan, Benjamin L. Ebert · 2017 · New England Journal of Medicine
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients
Paola Guglielmelli, Giada Rotunno, Annalisa Pacilli, Elisa Rumi, Vittorio Rosti, Federica Delaini, Margherita Maffioli, Tiziana Fanelli, Alessandro Pancrazzi, Lisa Pieri et al. · 2016 · American Journal of Hematology
RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses
Shady Adnan Awad, Olli Dufva, Aleksandr Ianevski, Bishwa R. Ghimire, Jan Koski, Pilvi Maliniemi, Daniel W. Thomson, ANDREAS W. SCHREIBER, Caroline Akemi Heckman, Perttu Koskenvesa et al. · 2020 · Leukemia
Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets
Svea Stratmann, Sara A. Yones, Markus Mayrhofer, Nina Norgren, Aron Skaftason, Jitong Sun, Karolina Smolińska, Jan Komorowski, Morten Krogh Herlin, Christer Sundström et al. · 2021 · Blood Advances
JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views
Naseema Gangat, Natasha Szuber, Animesh Dev Pardanani, Ayalew Tefferi · 2021 · Leukemia
VEXAS Syndrome: A Novelty in MDS Landscape
Marie Templé, Olivier Kosmider · 2022 · Diagnostics
DDX41-associated susceptibility to myeloid neoplasms
Hideki Makishima, Teresa Venezia Bowman, Lucy A. Godley · 2022 · Blood
Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms
Sanam Loghavi, Rashmi Kanagal‐Shamanna, Joseph David Khoury, Leonard Jeffrey Medeiros, Kikkeri N. Naresh, Reza Nejati, Mrinal M. Patnaik · 2023 · Modern Pathology
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial
Raajit K. Rampal, Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose, Aaron Thomas Gerds, Alessandro M. Vannucchi, Francesca Palandri, Sung‐Eun Lee, Vikas K Gupta et al. · 2025 · Nature Medicine
Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group (COG)
Sumit Gupta, Meenakshi Devidas, Mignon L. Loh, Elizabeth A. Raetz, Si Chen, Cindy Wang, Patrick Andrew Brown, Andrew J. Carroll, Nyla A. Heerema, Julie M. Gastier et al. · 2018 · Leukemia
Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3 ‐internal tandem duplication genotypes
Prajwal Chaitanya Boddu, Tapan Mahendra Kadia, Guillermo Garcia‐Manero, Jörge E. Cortes, Mansour Alfayez, Gautam M. Borthakur, Marina Y Konopleva, Elias Joseph Jabbour, Naval Guastad Daver, Courtney Denton Dinardo et al. · 2018 · Cancer
Automatic recognition of different types of acute leukaemia in peripheral blood by image analysis
Laura Boldú, Anna Merino, Santiago Alférez, Ángel Molina, Andrea Acevedo, José Rodellar · 2019 · Journal of Clinical Pathology
Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms
Mosca, Matthieu, Hermange, Gurvan, Tisserand, Amandine, Noble, Robert, Marzac, Christophe, Marty, Caroline, Le Sueur, Cécile, Campario, Hugo, Vertenoeil, Gaëlle, El-Khoury, Mira et al. · 2021 · Blood
Emerging strategies for high-risk and relapsed/refractory acute myeloid leukemia: Novel agents and approaches currently in clinical trials
Joshua P. Sasine, Gary John Schiller · 2014 · Blood Reviews
Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA
Nikola P. Konstandin, Friederike Pastore, Tobias Herold, Annika Maria Dufour, Maja Rothenberg‐Thurley, Tanja Hinrichsen, Bianka Ksienzyk, Sebastian Tschuri, Stephanie Schneider, Eva Hoster et al. · 2018 · Blood Advances